skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover idioma: Inglês remover nível superior: Recursos Online remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Boku, N. ; Ryu, M.-H. ; Kato, K. ; Chung, H.C. ; Minashi, K. ; Lee, K.-W. ; Cho, H. ; Kang, W.K. ; Komatsu, Y. ; Tsuda, M. ; Yamaguchi, K. ; Hara, H. ; Fumita, S. ; Azuma, M. ; Chen, L.-T. ; Kang, Y.-K.

Annals of oncology, 2019-02, Vol.30 (2), p.250-258 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Bang, Y.-J ; Ruiz, E.Yañez ; Van Cutsem, E. ; Lee, K.-W ; Wyrwicz, L. ; Schenker, M. ; Alsina, M. ; Ryu, M.-H ; Chung, H.-C ; Evesque, L. ; Al-Batran, S.-E ; Park, S.H. ; Lichinitser, M. ; Boku, N. ; Moehler, M.H. ; Hong, J. ; Xiong, H. ; Hallwachs, R. ; Conti, I. ; Taieb, J.

Annals of oncology, 2018-10, Vol.29 (10), p.2052-2060 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

Chen, J.S. ; Hsu, C. ; Chiang, N.J. ; Tsai, C.S. ; Tsou, H.H. ; Huang, S.F. ; Bai, L.Y. ; Chang, I.C. ; Shiah, H.S. ; Ho, C.L. ; Yen, C.J. ; Lee, K.D. ; Chiu, C.F. ; Rau, K.M. ; Yu, M.S. ; Yang, Y. ; Hsieh, R.K. ; Chang, J.Y. ; Shan, Y.S. ; Chao, Y. ; Chen, L.T. ; Shen, Wen-Chi ; Hsu, Hung-Chih ; Hsu, Chih-Hung ; Shen, Ying-Chun ; Wang, Tsang-En ; Li, Chung-Pin ; Chen, Ming-Huang ; Kao, Wei-Yao ; Chang, Ping-Ying ; Wu, Cheng-Chung ; Teng, Chien-Lin ; Lu, Chang-Hsien ; Lin, Shyh-Jer ; Wang, Being-Whey ; Chen, Yen-Yang ; Chin, Yung-Hsin ; Chung, Tsai-Rong ; Yu, Wei-Lan ; Lee, Mei-Hua ; Lin, Ling-Fang ; Lin, Pei-Chyi ; Wu, Ya-Ling ; Wang, Hui-Ling ; Lu, Li-Ju ; Chen, Shiang-Yi ; Wu, Chih-Chu ; Wei, Te-Chih

Annals of oncology, 2015-05, Vol.26 (5), p.943-949 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

Chung, J.H. ; Pavlick, D. ; Hartmaier, R. ; Schrock, A.B. ; Young, L. ; Forcier, B. ; Ye, P. ; Levin, M.K. ; Goldberg, M. ; Burris, H. ; Gay, L.M. ; Hoffman, A.D. ; Stephens, P.J. ; Frampton, G.M. ; Lipson, D.M. ; Nguyen, D.M. ; Ganesan, S. ; Park, B.H. ; Vahdat, L.T. ; Leyland-Jones, B. ; Mughal, T.I. ; Pusztai, L. ; O’Shaughnessy, J. ; Miller, V.A. ; Ross, J.S. ; Ali, S.M.

Annals of oncology, 2017-11, Vol.28 (11), p.2866-2873 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data
A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data

Satoh, T. ; Chen, L.-T. ; Kang, Y.-K. ; Chao, Y. ; Kato, K. ; Chung, H.C. ; Chen, J.-S. ; Muro, K. ; Kang, W.K. ; Yoshikawa, T. ; Oh, S.C. ; Tamura, T. ; Lee, K.-W. ; Boku, N.

Annals of oncology, 2018-10, Vol.29, p.viii206-viii206 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

Cheon, S.H. ; Rha, S.Y. ; Jeung, H.-C. ; Im, C.-K. ; Kim, S.H. ; Kim, H.R. ; Ahn, J.B. ; Roh, J.K. ; Noh, S.H. ; Chung, H.C.

Annals of oncology, 2008-06, Vol.19 (6), p.1146-1153 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors
Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Rosenthal, E.L. ; Chung, T.K. ; Parker, W.B. ; Allan, P.W. ; Clemons, L. ; Lowman, D. ; Hong, J. ; Hunt, F.R. ; Richman, J. ; Conry, R.M. ; Mannion, K. ; Carroll, W.R. ; Nabell, L. ; Sorscher, E.J.

Annals of oncology, 2015-07, Vol.26 (7), p.1481-1487 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Pembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study
Pembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study

Ueno, M. ; Chung, H.C. ; Nagrial, A. ; Marabelle, A. ; Kelley, R.K. ; Xu, L. ; Mahoney, J. ; Pruitt, S.K. ; Oh, D.-Y.

Annals of oncology, 2018-10, Vol.29, p.viii210-viii210 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

Boku, N. ; Ryu, M.H. ; Oh, D-Y. ; Oh, S.C. ; Chung, H.C. ; Lee, K-W. ; Omori, T. ; Shitara, K. ; Sakuramoto, S. ; Chung, I.J. ; Yamaguchi, K. ; Kato, K. ; Sym, S.J. ; Kadowaki, S. ; Tsuji, K. ; Chen, J-S. ; Bai, L-Y. ; Chen, L-T. ; Kang, Y-K.

Annals of oncology, 2020-09, Vol.31, p.S1192-S1192 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer

Shitara, K. ; Özgüroğlu, M. ; Bang, Y J ; Di Bartolomeo, M. ; Mandalà, M. ; Ryu, M H ; Fornaro, L. ; Olesiński, T. ; Caglevic, C. ; Chung, H. ; Muro, K. ; Gökkurt, E. ; Mansoor, W. ; McDermott, R. ; Schacham-Shmueli, E. ; Chen, X. ; Kang, S P ; Mayo, C. ; Ohtsu, A. ; Fuchs, C.

Annals of oncology, 2018-06, Vol.29, p.v123-v123 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.